The Long Run with Luke Timmerman cover image

Ep139: Kevin Conroy on Early Detection of Cancer

The Long Run with Luke Timmerman

CHAPTER

Cologard: A Commercial Launch

CMS did a deep analysis in parallel with FDA. And CMS looked at that and I mean, did its own analysis and thought based on the data, that's something we can pay for. They did. So having that national coverage decision and then a few months later pricing allowed us to launch cologard," he says. "We quickly shifted our whole mindset to a commercial launch"

00:00
Transcript
Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
App store bannerPlay store banner